Advertisement

Japanese Journal of Ophthalmology

, Volume 62, Issue 2, pp 151–157 | Cite as

Reduced light sensitivity due to impaired retinal perfusion in branch retinal vein occlusion

  • Hiroyuki IijimaEmail author
Clinical Investigation

Abstract

Purpose

To study the reduction in light sensitivity in areas where impaired retinal perfusion was established by fluorescein angiogram (FA) in eyes with branch retinal vein occlusion (BRVO) that recovered from retinal edema and hemorrhage.

Design

Retrospective observational case series.

Methods

A study of the reduction in light sensitivity demonstrated by total deviation display of the Humphrey perimetry program 30-2 in 43 eyes from 42 patients with BRVO, whose perfusion status was assessed by FA images taken at least 6 months after disease onset. Each of the 15 retinal squares in the FA images, corresponding to the 15 Humphrey test points around the fixation point in the affected vertical hemisphere, was classified as either perfused, partially perfused, or non-perfused. Correlation between light sensitivity and perfusion status was investigated by three evaluators in a total of 645 squares, 15 squares from each of the 43 subject eyes.

Results

In 459 retinal squares (71.2%) with complete agreement on the perfusion status among the three evaluators, light sensitivity was significantly different among retinal squares of perfused (median: − 4.0 dB, n = 258), partially perfused (median: − 8.0 dB, n = 41), and non-perfused (median: − 16.0 dB, n = 160) (P < .000001, Kruskal–Wallis test).

Conclusions

Light sensitivity is decreased in retinal areas exhibiting impaired perfusion, likely due to neuronal loss in the inner retinal layer in eyes with chronic BRVO.

Keywords

Light sensitivity Humphrey perimetry Branch retinal vein occlusion Perfusion Fluorescein angiogram 

Notes

Acknowledgements/Disclosure

This study was supported in part by a JSPS KAKENHI Grant Numbers 25462707 and 16K11263 (Grant-in-aid for scientific Research (C)) from the Japan Society for the Promotion of Science (JSPS), (Hiroyuki Iijima). The author thanks Yoichi Sakurada, MD, PhD, Seigo Yoneyama, MD, PhD and Mitsuhiro Imasawa, MD, PhD in University of Yamanashi Hospital for their assistance to evaluate perfusion status of 645 retinal squares in 43 fluorescein angiograms.

Conflicts of interest

H Iijima, None.

References

  1. 1.
    Group BVOS. Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Arch Ophthalmol. 1986;104:34–41.CrossRefGoogle Scholar
  2. 2.
    Lim HB, Kim MS, Jo YJ, Kim JY. Prediction of retinal ischemia in branch retinal vein occlusion: spectral-Domain Optical Coherence Tomography Study. Invest Ophthalmol Vis Sci. 2015;56:6622–9.  https://doi.org/10.1167/iovs.15-17678.CrossRefPubMedGoogle Scholar
  3. 3.
    Unoki N, Nishijima K, Sakamoto A, Kita M, Watanabe D, Hangai M, et al. Retinal sensitivity loss and structural disturbance in areas of capillary nonperfusion of eyes with diabetic retinopathy. Am J Ophthalmol. 2007;144:755–60.  https://doi.org/10.1016/j.ajo.2007.07.011.CrossRefPubMedGoogle Scholar
  4. 4.
    Yamaike N, Kita M, Tsujikawa A, Miyamoto K, Yoshimura N. Perimetric sensitivity with the micro perimeter 1 and retinal thickness in patients with branch retinal vein occlusion. Am J Ophthalmol. 2007;143:342–4.  https://doi.org/10.1016/j.ajo.2006.09.034.CrossRefPubMedGoogle Scholar
  5. 5.
    Imasawa M, Iijima H, Morimoto T. Perimetric sensitivity and retinal thickness in eyes with macular edema resulting from branch retinal vein occlusion. Am J Ophthalmol. 2001;131:55–60.CrossRefPubMedGoogle Scholar
  6. 6.
    Takahashi H, Iijima H. Sectoral thinning of the retina after branch retinal artery occlusion. Jpn J Ophthalmol. 2009;53:494–500.  https://doi.org/10.1007/s10384-009-0714-3.CrossRefPubMedGoogle Scholar
  7. 7.
    Noma H, Shimada K, Mimura T. Influence of retinal ischemia on macular function after pars plana vitrectomy for macular edema with branch retinal vein occlusion. Int Ophthalmol. 2013;33:677–86.  https://doi.org/10.1007/s10792-013-9762-2.CrossRefPubMedGoogle Scholar
  8. 8.
    Tadayoni R, Waldstein SM, Boscia F, Gerding H, Pearce I, Priglinger S, et al. Individualized stabilization criteria-driven ranibizumab versus laser in branch retinal vein occlusion: six-month results of BRIGHTER. Ophthalmology. 2016;123:1332–44.  https://doi.org/10.1016/j.ophtha.2016.02.030.CrossRefPubMedGoogle Scholar
  9. 9.
    Clark WL, Boyer DS, Heier JS, Brown DM, Haller JA, Vitti R, et al. Intravitreal aflibercept for macular edema following branch retinal vein occlusion: 52-week results of the VIBRANT Study. Ophthalmology. 2016;123:330–6.  https://doi.org/10.1016/j.ophtha.2015.09.035.CrossRefPubMedGoogle Scholar
  10. 10.
    Iesato Y, Imai A, Hirano T, Toriyama Y, Murata T. Effect of leaking capillaries and microaneurysms in the perifoveal capillary network on resolution of macular edema by anti-vascular endothelial growth factor treatment. Jpn J Ophthalmol. 2016;60:86–94.  https://doi.org/10.1007/s10384-016-0425-5.CrossRefPubMedGoogle Scholar

Copyright information

© Japanese Ophthalmological Society 2017

Authors and Affiliations

  1. 1.Department of OphthalmologyUniversity of YamanashiChuoJapan

Personalised recommendations